Skip to content
AnalystLens

Omega Healthcare Investors 8-K Report, Shareholder Vote Results (Jun 7, 2024)

Reports
Shareholder Matters
Filing Date
Filed June 7, 2024
Period End
June 7, 2024
Security
OHI
In the record · 2016–202610-K1210-Q348-K126

OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Jan ’23Jan ’23
  4. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 8-K filed June 7, 2024. Cited figures are marked; the original filing is the authoritative source.

Omega Healthcare Investors, Inc. ("Omega") held its Annual Meeting of Stockholders on June 7, 2024, according to this Current Report on Form 8-K.

Holders of 198,889,951 shares of common stock were present in person or represented by proxy, representing approximately 80.54%a of the total outstanding common stock as of the record date. Stockholders voted on three proposals. All eight director nominees were elected: Kapila K.

Anand, Craig R. Callen, Dr. Lisa C. Egbuonu-Davis, Barbara B.

Hill, Kevin J. Jacobs, C. Taylor Pickett, Stephen D.

Plavin, and Burke W. Whitman. Stockholders also ratified the selection of Ernst & Young LLP as Omega's independent auditor for fiscal year 2024, with 190,372,644 votes for and 7,992,692 against.

In a separate advisory vote, stockholders approved Omega's executive compensation, with 145,513,626 votes for, 8,549,668 against, and 1,081,137 abstentions. The filing reports voting results only.

It contains no financial results, guidance, or transaction disclosures. Plavin received the most votes against among the director nominees, at 8,793,871, while the other nominees drew between 1,446,209 and 3,667,932 votes against.

Key Highlights

  1. Annual Meeting held June 7, 2024, with holders of 198,889,951 shares present in person or by proxy, representing approximately 80.54% of total outstanding common stock as of the record date
  2. All eight director nominees were elected, including Kapila K. Anand, Craig R. Callen, Dr. Lisa C. Egbuonu-Davis, Barbara B. Hill, Kevin J. Jacobs, C. Taylor Pickett, Stephen D. Plavin, and Burke W. Whitman
  3. Stockholders ratified Ernst & Young LLP as independent auditor for fiscal year 2024, with 190,372,644 votes for and 7,992,692 against
  4. Advisory vote on executive compensation was approved, with 145,513,626 votes for, 8,549,668 against, and 1,081,137 abstentions
  5. Stephen D. Plavin drew the most votes against among director nominees, at 8,793,871
  6. Broker non-votes were 43,745,520 on the director election and executive compensation proposals
  7. The filing reports only Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 9.01 (Exhibit 104, the cover page interactive data file)

Frequently Asked Questions

  1. How much of Omega's common stock was represented at the June 7, 2024 Annual Meeting?

    Holders of 198,889,951 shares were present in person or represented by proxy, representing approximately 80.54% of the total outstanding common stock as of the record date.

  2. Which directors were elected at the Annual Meeting?

    All eight nominees were elected: Kapila K. Anand, Craig R. Callen, Dr. Lisa C. Egbuonu-Davis, Barbara B. Hill, Kevin J. Jacobs, C. Taylor Pickett, Stephen D. Plavin, and Burke W. Whitman.

  3. Did stockholders approve the executive compensation program?

    Yes. In an advisory vote, stockholders approved Omega's executive compensation, with 145,513,626 votes for, 8,549,668 against, and 1,081,137 abstentions.

  4. Who is Omega's independent auditor for fiscal year 2024?

    Stockholders ratified the selection of Ernst & Young LLP as Omega's independent auditor for fiscal year 2024, with 190,372,644 votes for, 7,992,692 against, and 524,615 abstentions.